PMID- 20495575 OWN - NLM STAT- MEDLINE DCOM- 20100603 LR - 20220408 IS - 1474-1768 (Electronic) IS - 1474-175X (Linking) VI - 10 IP - 6 DP - 2010 Jun TI - TGFbeta signalling: a complex web in cancer progression. PG - 415-24 LID - 10.1038/nrc2853 [doi] AB - The distortion of growth factor signalling is the most important prerequisite in tumour progression. Transforming growth factor-beta (TGFbeta) signalling regulates tumour progression by a tumour cell-autonomous mechanism or through tumour-stroma interaction, and has either a tumour-suppressing or tumour-promoting function depending on cellular context. Such inherent complexity of TGFbeta signalling results in arduous, but promising, assignments for developing therapeutic strategies against malignant tumours. As numerous cellular context-dependent factors tightly maintain the balance of TGFbeta signalling and contribute to the regulation of TGFbeta-induced cell responses, in this Review we discuss how they maintain the balance of TGFbeta signalling and how their collapse leads to tumour progression. FAU - Ikushima, Hiroaki AU - Ikushima H AD - Department of Molecular Pathology, Graduate School of Medicine, University of Tokyo, Tokyo 113-0033, Japan. FAU - Miyazono, Kohei AU - Miyazono K LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review PL - England TA - Nat Rev Cancer JT - Nature reviews. Cancer JID - 101124168 RN - 0 (Transforming Growth Factor beta) SB - IM MH - Animals MH - *Disease Progression MH - Humans MH - Neoplasm Metastasis MH - Neoplasms/blood supply/genetics/*metabolism/*pathology MH - Neovascularization, Pathologic MH - *Signal Transduction MH - Transforming Growth Factor beta/genetics/*metabolism RF - 129 EDAT- 2010/05/25 06:00 MHDA- 2010/06/04 06:00 CRDT- 2010/05/25 06:00 PHST- 2010/05/25 06:00 [entrez] PHST- 2010/05/25 06:00 [pubmed] PHST- 2010/06/04 06:00 [medline] AID - nrc2853 [pii] AID - 10.1038/nrc2853 [doi] PST - ppublish SO - Nat Rev Cancer. 2010 Jun;10(6):415-24. doi: 10.1038/nrc2853.